Catena Biosciences

Catena Biosciences develops protein- and cell-based therapies via enzyme-based protein-to-protein attachment. The company’s technology can conjugate any two soluble proteins together — including large, complex proteins not suitable for traditional approaches — without extensive modification. Catena can also vary which

Catena Biosciences is a company in health based in San Francisco, CA, USA; Berkeley, CA, USA.

Profile

Catena Biosciences develops protein- and cell-based therapies via enzyme-based protein-to-protein attachment. The company’s technology can conjugate any two soluble proteins together — including large, complex proteins not suitable for traditional approaches — without extensive modification. Catena can also vary which attachment sites are used and how much attachment occurs to customize therapies.

Within the health space, the company focuses on its core offering rather than a broad product line.

The business is associated with San Francisco, CA, USA; Berkeley, CA, USA.

The company is listed at the Summer 2021 stage of development.

Recorded headcount: 7 employees.

Website: www.catenabiosciences.com